Terms: = Colorectal cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2
6624 results:
1. Tissue Elasticity as a Diagnostic Marker of Molecular Mutations in Morphologically Heterogeneous colorectal cancer.
Plekhanov AA; Kozlov DS; Shepeleva AA; Kiseleva EB; Shimolina LE; Druzhkova IN; Plekhanova MA; Karabut MM; Gubarkova EV; Gavrina AI; Krylov DP; Sovetsky AA; Gamayunov SV; Kuznetsova DS; Zaitsev VY; Sirotkina MA; Gladkova ND
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791375
[TBL] [Abstract] [Full Text] [Related]
2. ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in cancer Cells.
Wu CP; Hung CY; Murakami M; Wu YS; Chu YH; Huang YH; Yu JS; Ambudkar SV
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791198
[TBL] [Abstract] [Full Text] [Related]
3. [Incidence of common gene mutations in early-onset colorectal cancer and the association with cancer survival: a meta-analysis].
Zhang RQ; Li SH; Hu TJ; Xu LY; Zhu YS; Li X
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):495-506. PubMed ID: 38778689
[TBL] [Abstract] [Full Text] [Related]
4. RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification.
Lee SM; Oh H
Sci Rep; 2024 May; 14(1):11432. PubMed ID: 38763942
[TBL] [Abstract] [Full Text] [Related]
5. Molecular Deciphering of colorectal cancer: Exploring Molecular Classifications and Analyzing the Interplay among Molecular Biomarkers MMR/MSI, kras, NRAS, BRAF and CDX2 - A Comprehensive Literature Review.
Ilie-Petrov AC; Cristian DA; Diaconescu AS; Chitul A; Blajin A; Popa A; Mandi DM; Negreanu R; Vieru C; Vrîncianu R; Ardeleanu CM
Chirurgia (Bucur); 2024 Apr; 119(2):136-155. PubMed ID: 38743828
[No Abstract] [Full Text] [Related]
6. Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in
Zhang H; Read A; Cataisson C; Yang HH; Lee WC; Turk BE; Yuspa SH; Luo J
Sci Signal; 2024 May; 17(836):eadd5073. PubMed ID: 38743809
[TBL] [Abstract] [Full Text] [Related]
7. Divarasib in the Evolving Landscape of kras G12C Inhibitors for NSCLC.
Brazel D; Nagasaka M
Target Oncol; 2024 May; 19(3):297-301. PubMed ID: 38739329
[TBL] [Abstract] [Full Text] [Related]
8. Distinct Driver Pathway Enrichments and a High Prevalence of
Tapia-Valladares C; Valenzuela G; González E; Maureira I; Toro J; Freire M; Sepúlveda-Hermosilla G; Ampuero D; Blanco A; Gallegos I; Morales F; Erices JI; Barajas O; Ahumada M; Contreras HR; González J; Armisén R; Marcelain K
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731914
[TBL] [Abstract] [Full Text] [Related]
9. Activity and resistance to kras
Ye W; Lu X; Qiao Y; Ou WB
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189108. PubMed ID: 38723697
[TBL] [Abstract] [Full Text] [Related]
10. Use of Deep Learning to Evaluate Tumor Microenvironmental Features for Prediction of Colon cancer Recurrence.
Sinicrope FA; Nelson GD; Saberzadeh-Ardestani B; Segovia DI; Graham RP; Wu C; Hagen CE; Shivji S; Savage P; Buchanan DD; Jenkins MA; Phipps AI; Swallow C; LeMarchand L; Gallinger S; Grant RC; Pai RK; Sinicrope SN; Yan D; Shanmugam K; Conner J; Cyr DP; Kirsch R; Banerjee I; Alberts SR; Shi Q; Pai RK
Cancer Res Commun; 2024 May; 4(5):1344-1350. PubMed ID: 38709069
[TBL] [Abstract] [Full Text] [Related]
11. Construction and validation of "WCH-nomogram" for predicting the prognosis after resection of colorectal liver metastases.
Jiang C; Liu W; Jin Z; Lan L; Xu L; Du A; Peng S; Zeng Y; Wang H; Liao M; Zhou J
Cancer Med; 2024 May; 13(9):e7222. PubMed ID: 38698687
[TBL] [Abstract] [Full Text] [Related]
12. Sarcopenic Obesity Promotes Recurrence in Patients Undergoing Resection for colorectal Liver Metastases (CRLM).
Wagner D; Karitnig R; Wienerroither V; Hau HM; Lederer A; Sucher R; Kornprat P
Anticancer Res; 2024 May; 44(5):2177-2183. PubMed ID: 38677767
[TBL] [Abstract] [Full Text] [Related]
13. Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study.
Dreikhausen L; Klupsch A; Wiest I; Xiao Q; Schulte N; Betge J; Boch T; Brochhausen C; Gaiser T; Hofheinz RD; Ebert M; Zhan T
BMC Cancer; 2024 Apr; 24(1):526. PubMed ID: 38664720
[TBL] [Abstract] [Full Text] [Related]
14. Precursor-Directed Biosynthesis of Neoantimycin Derivatives with Selective Cytotoxicity.
Li Z; Chai L; Tang Z; Zhu H; Xue P; Sun F; Lin H; Zhou Y; Lin X
J Nat Prod; 2024 May; 87(5):1376-1383. PubMed ID: 38662398
[TBL] [Abstract] [Full Text] [Related]
15. Weighting estimation in the cause-specific Cox regression with partially missing causes of failure.
Lee J; Ogino S; Wang M
Stat Med; 2024 Jun; 43(13):2575-2591. PubMed ID: 38659326
[TBL] [Abstract] [Full Text] [Related]
16. Temporal trends and regional variability in BRAF and kras genetic testing in Denmark (2010-2022): Implications for precision medicine.
Frost MG; Jensen KJ; Jimenez-Solem E; Qvortrup C; Kuhlmann TP; Andersen JL; Høgdall E; Petersen TS
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23236. PubMed ID: 38656617
[TBL] [Abstract] [Full Text] [Related]
17. Adjuvant chemotherapy is associated with better oncological outcomes after ALPPS for colorectal liver metastases.
Alvarez FA; Ardiles V; Chara C; de Santibañes M; Sánchez Clariá R; Pekolj J; de Santibañes E
Updates Surg; 2024 Jun; 76(3):855-868. PubMed ID: 38647857
[TBL] [Abstract] [Full Text] [Related]
18. Complete remission in a pretreated, microsatellite-stable,
He L; Li H; Wang Y; Li W; Gao L; Xu B; Hu J; He P; Pu W; Sun G; Wang Z; Han Q; Liu B; Chen H
Front Immunol; 2024; 15():1354613. PubMed ID: 38617840
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic value of specific kras mutations in patients with colorectal peritoneal metastases.
Tonello M; Baratti D; Sammartino P; Di Giorgio A; Robella M; Sassaroli C; Framarini M; Valle M; Macrì A; Graziosi L; Coccolini F; Lippolis PV; Gelmini R; Deraco M; Biacchi D; Aulicino M; Vaira M; De Franciscis S; D'Acapito F; Carboni F; Milone E; Donini A; Fugazzola P; Faviana P; Sorrentino L; Pizzolato E; Cenzi C; Del Bianco P; Sommariva A
ESMO Open; 2024 Apr; 9(4):102976. PubMed ID: 38613907
[TBL] [Abstract] [Full Text] [Related]
20. Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic colorectal cancer Patients: A Multicenter Retrospective Analysis.
Basso M; Signorelli C; Calegari MA; Lucchetti J; Zurlo IV; Dell'Aquila E; Arrivi G; Zoratto F; Santamaria F; Saltarelli R; Trovato G; Caira G; Angotti L; Schirripa M; Anghelone A; Schietroma F; Chilelli MG; Salvatore L; Pozzo C; Tortora G
Target Oncol; 2024 May; 19(3):371-382. PubMed ID: 38613732
[TBL] [Abstract] [Full Text] [Related]
[Next]
